COVA-301

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCOVA-301
Drug Alias NameCOVA-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin 17A inhibitors
TargetsTumor necrosis factor αInterleukin 17A
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCovagen Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCovagen Ag
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A